These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. [3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein. Strauss M, O'Donovan B, Ma Y, Xiao Z, Lin S, Bardo MT, Ortinski PI, McLaughlin JP, Zhu J. J Pharmacol Exp Ther; 2020 Aug 01; 374(2):241-251. PubMed ID: 32461322 [Abstract] [Full Text] [Related]
36. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909). Matecka D, Rothman RB, Radesca L, de Costa BR, Dersch CM, Partilla JS, Pert A, Glowa JR, Wojnicki FH, Rice KC. J Med Chem; 1996 Nov 22; 39(24):4704-16. PubMed ID: 8941383 [Abstract] [Full Text] [Related]
37. The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study. Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM. Neuroscience; 2009 Apr 10; 159(4):1292-9. PubMed ID: 19344635 [Abstract] [Full Text] [Related]
39. Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. Andersen PH. J Neurochem; 1987 Jun 10; 48(6):1887-96. PubMed ID: 2952763 [Abstract] [Full Text] [Related]